Zoekresultaten - 2794 results
Training on the assessment of quality part (M3) of the eCTD for the registration of vaccines for human use
registration of vaccines for human use, Sciensano, Brussels, Belgium (2023) Keywords: assessment module 3 vaccines Health Topics: Vaccine batch conformity Vaccin lot conformiteit Conformité de lot de vaccin ...
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
978-92-9498-674-0 Accession Number: NA URL: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-vaccine-effectiveness-hospitalisation.pdf Keywords: COVID-19 Multi-country Vaccine effectiveness Abstract: ...
The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa
the development of an anti-virulence compound that targets the bacterial TCS. Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories ...
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium
Source: BMC Res Notes, Volume 16, Issue 1 (2023) Keywords: Adult Aged Belgium Biological Transport COVID-19 COVID-19 Vaccines Female Humans Immunization Programs Male Vaccination Abstract: OBJECTIVE: This ...
Outbreak of Corynebacterium diphtheriae among asylum seekers in Belgium in 2022: operational challenges and lessons learnt.
isolation and contact tracing of cases was not possible. A vaccination centre was opened, and mobile vaccination campaigns were organised to vaccinate a maximum of asylum seekers. No more cases were detected ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Publication Type: Peer reviewed scientific article Authors: Meslé, Margaux M I; Sinnathamby, Mary; Mook, Piers; WHO European Region Respiratory Network Group; Pebody, Richard; Lakhani, Anissa; Zambon, Maria; Popovici, Odette; Lazar, Mihaela; Ljubović, Ame ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Vaccines Europe Hospitalization Humans Pneumonia RNA, Messenger SARS-CoV-2 Vaccine Efficacy Abstract: IntroductionThe I- MOVE- COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
study teams (in addition to the named authors) Source: Euro Surveill, Volume 28, Issue 47 (2023) Keywords: Adult BNT162 Vaccine COVID-19 Europe Hospitalization Humans RNA, Viral SARS-CoV-2 Vaccine ...
Complete genome reconstruction of the global and European regional dispersal history of the lumpy skin disease virus.
circulation of vaccine-like recombinants, and the use of vaccines. The slow molecular evolution of its DNA genome limits the utility of genetic variation for accurate tracing based on evolutionary analyses, but ...